Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Silvia Ferrer López

Silvia Ferrer López

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Silvia Ferrer López

Silvia Ferrer López

Silvia Ferrer López

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

Dr. Xavier Montalban, Dr. Mar Tintoré and Dr. René Carvajal

Age and treatment may predict risk of multiple sclerosis reactivation

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

Laboratori

Viva in Vitro and Vall d’Hebron will study biomarkers in multiple sclerosis

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

Dr Mar Tintoré and Dr Álvaro Cobo Calvo

Ovarian reserve does not predict the course of multiple sclerosis

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

See more

Related professionals

Monica Kruger

Monica Kruger

Research technician
Pneumology
Read more
Gerard Roch Alba

Gerard Roch Alba

Predoctoral researcher
Neurodegenerative Diseases
Read more
Paul Gerard Buck Espel

Paul Gerard Buck Espel

Predoctoral researcher
Ophtalmology
Read more
Nuria Marques Calvo

Nuria Marques Calvo

Research assistant
Molecular Imaging and Therapy
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.